Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Applied and Environmental Microbiology|October 1, 1988
Rapid hydrophobic grid membrane filter-enzyme-labeled antibody procedure for identification and enumeration of Escherichia coli O157 in foodsE C Todd, R A Szabo, P Peterkin, et al.
Journal of the American College of Cardiology|November 7, 1999
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular EnlargementV Palmieri, B Dahlöf, V DeQuattro, et al.
British Journal of Rheumatology|October 1, 1996
Left ventricular function in sclerodermaG P Armstrong, G A Whalley, R N Doughty, et al.
Applied and Environmental Microbiology|January 22, 1998
Measurement of antimicrobial-resistant Escherichia coli in pig feces with a hydrophobic grid membrane filter interpreter systemR H Dunlop, S A McEwen, A H Meek, et al.
Lancet (London, England)|October 20, 1984
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranololR M Norris, P F Barnaby, M A Brown, et al.
Lancet (London, England)|July 2, 1988
Patent foramen ovale in young stroke patientsM W Webster, A M Chancellor, H J Smith, et al.
Journal of Nephrology|January 1, 1997
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative GroupR Robson, J Collins, R Johnson, et al.
Circulation|February 17, 1999
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Canadian Journal of Microbiology|October 1, 1983
Collaborative study of the MPN, Anderson-Baird-Parker direct plating, and hydrophobic grid-membrane filter methods for the enumeration of Escherichia coli biotype I in foodsA N Sharpe, M K Rayman, D M Burgener, et al.
Journal of the American College of Cardiology|June 13, 2001
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure GroupA M Richards, R Doughty, M G Nicholls, et al.
Pageof 18